Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Racca

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Minerva Medica|January 14, 1986
[Tumor-associated markers in malignant lung neoplasms]G Piancino, P Racca, W Rayneri, et al.
La Radiologia Medica|March 21, 2012
Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survivalA Veltri, T Guarnieri, C Gazzera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 3, 2016
Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancerP Franco, R Ragona, F Arcadipane, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 23, 2013
A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impactM Mistrangelo, R Senetta, P Racca, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2016
Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal CancerA R Filippi, F Guerrera, S Badellino, et al.
British Journal of Cancer|January 19, 2013
Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literatureD M Mistrangelo, M Bellò, P Cassoni, et al.
Chronobiology International|November 6, 2015
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapyM Tampellini, R S Polverari, A Ottone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONOC Cremolini, C Antoniotti, S Lonardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONOE Dell'Aquila, C Cremolini, T Zeppola, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Minerva Medica|January 14, 1986
[Tumor-associated markers in malignant lung neoplasms]G Piancino, P Racca, W Rayneri, et al.
La Radiologia Medica|March 21, 2012
Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survivalA Veltri, T Guarnieri, C Gazzera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 3, 2016
Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancerP Franco, R Ragona, F Arcadipane, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 23, 2013
A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impactM Mistrangelo, R Senetta, P Racca, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2016
Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal CancerA R Filippi, F Guerrera, S Badellino, et al.
British Journal of Cancer|January 19, 2013
Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literatureD M Mistrangelo, M Bellò, P Cassoni, et al.
Chronobiology International|November 6, 2015
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapyM Tampellini, R S Polverari, A Ottone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONOC Cremolini, C Antoniotti, S Lonardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONOE Dell'Aquila, C Cremolini, T Zeppola, et al.
Pageof 1